Clinical Trial Update: Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia

View source ↗

Summary

A clinical trial evaluating dolasetron to prevent chemotherapy-induced nausea and vomiting in children with acute lymphoblastic leukemia is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Anzemet (dolasetron)

Snippet

Sponsor: Anhui Provincial Children's Hospital | Conditions: Chemotherapy Induced Nausea and Vomiting | Status: RECRUITING